Literature DB >> 23061605

Reactive metabolites in the biotransformation of molecules containing a furan ring.

Lisa A Peterson1.   

Abstract

Many xenobiotics containing a furan ring are toxic and/or n class="Disease">carcinogenic. The harmful effects of these compounds require furan ring oxidation. This reaction generates an electrophilic intermediate. Depending on the furan ring substituents, the intermediate is either an epoxide or a cis-enedione with more ring substitution favoring epoxide formation. Either intermediate reacts with cellular nucleophiles such as protein or DNA to trigger toxicities. The reactivity of the metabolite determines which cellular nucleophiles are targeted. The toxicity of a particular furan is also influenced by the presence of competing metabolic pathways or efficient detoxification routes. GSH plays an important role in modulating the harmful effects of this class of compound by reacting with the reactive metabolite. However, this may not represent a detoxification step in all cases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23061605      PMCID: PMC3574180          DOI: 10.1021/tx3003824

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  154 in total

1.  Bromobenzene and furosemide hepatotoxicity: alterations in glutathione, protein thiols, and calcium.

Authors:  K K Grewal; E Rafeiro; W J Racz
Journal:  Can J Physiol Pharmacol       Date:  1996-03       Impact factor: 2.273

2.  In vivo genotoxicity of furan in F344 rats at cancer bioassay doses.

Authors:  Wei Ding; Dayton M Petibone; John R Latendresse; Mason G Pearce; Levan Muskhelishvili; Gene A White; Ching-Wei Chang; Roberta A Mittelstaedt; Joseph G Shaddock; Lea P McDaniel; Daniel R Doerge; Suzanne M Morris; Michelle E Bishop; Mugimane G Manjanatha; Anane Aidoo; Robert H Heflich
Journal:  Toxicol Appl Pharmacol       Date:  2012-04-05       Impact factor: 4.219

3.  The in vitro formation of glutathione conjugates with the microsomally activated pulmonary bronchiolar aklylating agent and cytotoxin, 4-ipomeanol.

Authors:  A R Buckpitt; M R Boyd
Journal:  J Pharmacol Exp Ther       Date:  1980-10       Impact factor: 4.030

4.  Effects of menthofuran, a monoterpene furan on rat liver microsomal enzymes, in vivo.

Authors:  K M Madyastha; C P Raj
Journal:  Toxicology       Date:  1994-04-18       Impact factor: 4.221

5.  Hepatotoxicity of germander (Teucrium chamaedrys L.) and one of its constituent neoclerodane diterpenes teucrin A in the mouse.

Authors:  S A Kouzi; R J McMurtry; S D Nelson
Journal:  Chem Res Toxicol       Date:  1994 Nov-Dec       Impact factor: 3.739

6.  Long-term effects of repeated exposure to 3-methylfuran in hamsters and mice.

Authors:  H P Witschi; A F Tryka; J L Mauderly; W M Haschek; L C Satterfield; N D Bowles; M R Boyd
Journal:  J Toxicol Environ Health       Date:  1985

7.  Effects of phenobarbital and 3-methylcholanthrene on the in vivo distribution, metabolism and covalent binding of 4-ipomeanol in the rat; implications for target organ toxicity.

Authors:  C N Statham; M R Boyd
Journal:  Biochem Pharmacol       Date:  1982-12-15       Impact factor: 5.858

Review 8.  Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature.

Authors:  I B Anderson; W H Mullen; J E Meeker; S Oishi; S D Nelson; P D Blanc
Journal:  Ann Intern Med       Date:  1996-04-15       Impact factor: 25.391

9.  Reaction of alpha-acetoxy-N-nitrosopiperidine with deoxyguanosine: oxygen-dependent formation of 4-oxo-2-pentenal and a 1,N2-ethenodeoxyguanosine adduct.

Authors:  S S Hecht; R Young-Sciame; F L Chung
Journal:  Chem Res Toxicol       Date:  1992 Sep-Oct       Impact factor: 3.739

10.  2-Methylfuran toxicity in rats--role of metabolic activation in vivo.

Authors:  V Ravindranath; M G McMenamin; J H Dees; M R Boyd
Journal:  Toxicol Appl Pharmacol       Date:  1986-08       Impact factor: 4.219

View more
  28 in total

Review 1.  Neoclerodanes as atypical opioid receptor ligands.

Authors:  Thomas E Prisinzano
Journal:  J Med Chem       Date:  2013-04-18       Impact factor: 7.446

Review 2.  The status of isocyanide-based multi-component reactions in Iran (2010-2018).

Authors:  Ronak Afshari; Seyyed Emad Hooshmand; Mohammad Taghi Nazeri; Siamak Javanbakht; Ahmad Shaabani; Reza Mohammadian
Journal:  Mol Divers       Date:  2020-02-18       Impact factor: 2.943

3.  Microbial biotransformation of furosemide for environmental risk assessment: identification of metabolites and toxicological evaluation.

Authors:  Hugo Olvera-Vargas; Sébastien Leroy; Michael Rivard; Nihal Oturan; Mehmet Oturan; Didier Buisson
Journal:  Environ Sci Pollut Res Int       Date:  2016-08-25       Impact factor: 4.223

4.  Computational Approach to Structural Alerts: Furans, Phenols, Nitroaromatics, and Thiophenes.

Authors:  Na Le Dang; Tyler B Hughes; Grover P Miller; S Joshua Swamidass
Journal:  Chem Res Toxicol       Date:  2017-03-14       Impact factor: 3.739

5.  In Vitro and In Vivo Metabolite Identification Studies for the New Synthetic Opioids Acetylfentanyl, Acrylfentanyl, Furanylfentanyl, and 4-Fluoro-Isobutyrylfentanyl.

Authors:  Shimpei Watanabe; Svante Vikingsson; Markus Roman; Henrik Green; Robert Kronstrand; Ariane Wohlfarth
Journal:  AAPS J       Date:  2017-04-05       Impact factor: 4.009

6.  Synthetic molecules for disruption of the MYC protein-protein interface.

Authors:  Nicholas T Jacob; Pedro O Miranda; Ryan J Shirey; Ritika Gautam; Bin Zhou; M Elena de Orbe Izquierdo; Mark S Hixon; Jonathan R Hart; Lynn Ueno; Peter K Vogt; Kim D Janda
Journal:  Bioorg Med Chem       Date:  2018-07-11       Impact factor: 3.641

7.  A Ligand-Based Drug Design. Discovery of 4-Trifluoromethyl-7,8-pyranocoumarin as a Selective Inhibitor of Human Cytochrome P450 1A2.

Authors:  Jiawang Liu; Peter T Pham; Elena V Skripnikova; Shilong Zheng; La'nese J Lovings; Yuji Wang; Navneet Goyal; Sydni M Bellow; Lydia M Mensah; Amari J Chatters; Melyssa R Bratton; Thomas E Wiese; Ming Zhao; Guangdi Wang; Maryam Foroozesh
Journal:  J Med Chem       Date:  2015-08-10       Impact factor: 7.446

8.  Discovery of Quinazolines That Activate SOS1-Mediated Nucleotide Exchange on RAS.

Authors:  Jason R Abbott; Pratiq A Patel; Jennifer E Howes; Denis T Akan; J Phillip Kennedy; Michael C Burns; Carrie F Browning; Qi Sun; Olivia W Rossanese; Jason Phan; Alex G Waterson; Stephen W Fesik
Journal:  ACS Med Chem Lett       Date:  2018-08-08       Impact factor: 4.345

9.  Chlorination of Phenols Revisited: Unexpected Formation of α,β-Unsaturated C4-Dicarbonyl Ring Cleavage Products.

Authors:  Carsten Prasse; Urs von Gunten; David L Sedlak
Journal:  Environ Sci Technol       Date:  2020-01-06       Impact factor: 9.028

10.  Development of an allosteric inhibitor class blocking RNA elongation by the respiratory syncytial virus polymerase complex.

Authors:  Robert M Cox; Mart Toots; Jeong-Joong Yoon; Julien Sourimant; Barbara Ludeke; Rachel Fearns; Elyse Bourque; Joseph Patti; Edward Lee; John Vernachio; Richard K Plemper
Journal:  J Biol Chem       Date:  2018-09-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.